Svetlana Ivanovna Pavlova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Svetlana Ivanovna Pavlova has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Evgeniy Aleksandrovich Lyubimov
ФГБУ «Федеральный центр травматологии, ортопедии и эндопротезирования» Минздрава России (г. Чебоксары)
5 shared publications - Lyudmila Valentinovna Lyubimova
ФГБУ "Федеральный центр травматологии, ортопедии и эндопротезирования" Минздрава России (г. Чебоксары)
5 shared publications - Ksenia S. Georgieva
Chuvash State University
4 shared publications O. S. Laptev
Department of Pharmacology, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
4 shared publicationsD. Z. Albegova
Department of Pharmacology, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
3 shared publicationsI. G. Kozlov
Department of Pharmacology, N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia
3 shared publications
Latest Publications
- 28 August 2026
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 104 (6) , 463-470
Mathematical modeling of the expected effectiveness of empirical antibiotic therapy for peri-prosthetic infection
Periprosthetic infection (PJI) is a serious problem in orthopedic practice. In the case of an unknown pathogen, empirical antibiotic therapy is based on local epidemiological data. The aim of this study is to calculate the expected effectiveness of empirical antibiotic therapy based on microbiological monitoring of PJI pathogens using mathematical modeling. Material and methods. A retrospective analysis of 379 bacterial isolates isolated in the PJI of the hip, knee and shoulder joints (2018–2024) was carried out. Microbiological identification and sensitivity testing were performed using standard methods. The indicator of expected empirical eff ectiveness (IEEE) of antibiotics was calculated. Results . The incidence of coagulase-negative staphylococci (CoNS) was 39.6%, Staphylococcus aureus was 28.5%, gram-negative bacteria was 10.3%, Streptococcus was 8.7%, and Enterococcus was 5.3%. Antibiotics with consistently high IEEE (≥ 80% in all periods) were identifi ed: vancomycin, linezolid, and tigecycline; with an average IEEE (50–79%) — include ciprofl oxacin/levofl oxacin, clindamycin, tetracycline, rifampicin, aminoglycosides, trimethoprim-sulfamethoxazole, and meropenem; with a low IEEE (≤ 49%) — include erythromycin, aztreonam, and tobramycin. A negative trend of decreasing the sensitivity of CoNS to fl uoroquinolones (from 70.0 to 47.3%; p =0.014), co-trimoxazole (from 82.0 to 55.9%; p =0.007) was revealed. The optimal combination for the starting empiric therapy is the scheme «vancomycin+meropenem » with the estimated calculated effi ciency ≥ 87.4% against more than 90% of the pathogens of PJI. Сonclusion. Mathematical modeling of the effectiveness of antibiotic therapy based on local data on pathogens and their sensitivity is a promising tool for optimizing empiric therapy for PJI.
- 28 August 2026
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 104 (6) , 463-470
Mathematical modeling of the expected effectiveness of empirical antibiotic therapy for peri-prosthetic infection
Periprosthetic infection (PJI) is a serious problem in orthopedic practice. In the case of an unknown pathogen, empirical antibiotic therapy is based on local epidemiological data. The aim of this study is to calculate the expected effectiveness of empirical antibiotic therapy based on microbiological monitoring of PJI pathogens using mathematical modeling. Material and methods. A retrospective analysis of 379 bacterial isolates isolated in the PJI of the hip, knee and shoulder joints (2018–2024) was carried out. Microbiological identification and sensitivity testing were performed using standard methods. The indicator of expected empirical eff ectiveness (IEEE) of antibiotics was calculated. Results . The incidence of coagulase-negative staphylococci (CoNS) was 39.6%, Staphylococcus aureus was 28.5%, gram-negative bacteria was 10.3%, Streptococcus was 8.7%, and Enterococcus was 5.3%. Antibiotics with consistently high IEEE (≥ 80% in all periods) were identifi ed: vancomycin, linezolid, and tigecycline; with an average IEEE (50–79%) — include ciprofl oxacin/levofl oxacin, clindamycin, tetracycline, rifampicin, aminoglycosides, trimethoprim-sulfamethoxazole, and meropenem; with a low IEEE (≤ 49%) — include erythromycin, aztreonam, and tobramycin. A negative trend of decreasing the sensitivity of CoNS to fl uoroquinolones (from 70.0 to 47.3%; p =0.014), co-trimoxazole (from 82.0 to 55.9%; p =0.007) was revealed. The optimal combination for the starting empiric therapy is the scheme «vancomycin+meropenem » with the estimated calculated effi ciency ≥ 87.4% against more than 90% of the pathogens of PJI. Сonclusion. Mathematical modeling of the effectiveness of antibiotic therapy based on local data on pathogens and their sensitivity is a promising tool for optimizing empiric therapy for PJI.
- Open Access
- 15 August 2026
- Published by Publishing House OKI in Pharmacogenetics and Pharmacogenomics
- No. 2,p. 95-105
CYP2C19 and ABCB1 polymorphisms in patients of Chuvash ethnic group: assessment of clopidogrel resistance and associations with recurrent myocardial infarction
Background. The prevalence of clopidogrel resistance among patients with cardiovascular diseases (CVD) reaches 30–40 %, significantly increasing the risk of recurrent myocardial infarction (MI) and other thrombotic events. Genetic polymorphisms in CYP2C19 and ABCB1 account for up to 40 % of the variability in antiplatelet response; however, data on Turkic populations, including the Chuvash, remain fragmentary. Objective. To determine the frequencies of CYP2C19 (*2, *3, *17) and ABCB1 C3435T polymorphisms, as well as their association with recurrent MI and clopidogrel resistance in patients of Chuvash ethnic origin with CVD, including acute coronary syndrome (ACS). Materials and methods. This prospective cohort study included 216 Chuvash patients (mean age 66.5 years) with CVD, including ACS, receiving dual antiplatelet therapy with clopidogrel. Genotyping of CYP2C19 (*2, *3, *17) and ABCB1 (3435C>T) polymorphisms was performed using real-time PCR. In a subgroup of ACS patients (n=30), ADP-induced platelet aGGreGAtion was assessed turbidimetrically on day 7 of therapy. Results. Among Chuvash patients, a high frequency of minor alleles was observed: ABCB1 C3435T — 60.6 %, CYP2C1917 (–806C>T) — 28.7 %, whereas the frequencies of CYP2C192 and CYP2C193 were low (9.05 % and 1.85 %, respectively). Heterozygous CT genotype of CYP2C19*17 was associated with a higher rate of recurrent MI both in the overall cohort (19.8 % vs. 8.5 % in CC carriers; p=0.049) and in the ACS subgroup (30.2 % vs. 12.9 %; p=0.037, p~CC–CT~ =0.044). Laboratory platelet aGGreGAtion assessment revealed that the highest proportion of antiplateletresistant patients was observed among heterozygotes carrying the *1/*17 genotype (rapid metabolizer phenotype), whereas no resistance cases were recorded among *17/*17 homozygotes (ultrarapid metabolizers). No statistically significant associations with recurrent MI were found for CYP2C192, CYP2C193, or ABCB1 polymorphisms. Conclusion. In Chuvash patients with CVD, including ACS, heterozygous carriage of CYP2C1917 is associated with recurrent MI, which contradicts the expected enhancement of clopidogrel antiplatelet effect (rapid metabolizer phenotype). This may indicate possible phenoconversion due to the interplay of genetic factors (ABCB1 C3435T) and drug — drug interactions (concomitant omeprazole use).
- 15 August 2026
- Published by Publishing House OKI in Pharmacogenetics and Pharmacogenomics
- No. 2,p. 95-105
Open AccessCYP2C19 and ABCB1 polymorphisms in patients of Chuvash ethnic group: assessment of clopidogrel resistance and associations with recurrent myocardial infarction
Background. The prevalence of clopidogrel resistance among patients with cardiovascular diseases (CVD) reaches 30–40 %, significantly increasing the risk of recurrent myocardial infarction (MI) and other thrombotic events. Genetic polymorphisms in CYP2C19 and ABCB1 account for up to 40 % of the variability in antiplatelet response; however, data on Turkic populations, including the Chuvash, remain fragmentary. Objective. To determine the frequencies of CYP2C19 (*2, *3, *17) and ABCB1 C3435T polymorphisms, as well as their association with recurrent MI and clopidogrel resistance in patients of Chuvash ethnic origin with CVD, including acute coronary syndrome (ACS). Materials and methods. This prospective cohort study included 216 Chuvash patients (mean age 66.5 years) with CVD, including ACS, receiving dual antiplatelet therapy with clopidogrel. Genotyping of CYP2C19 (*2, *3, *17) and ABCB1 (3435C>T) polymorphisms was performed using real-time PCR. In a subgroup of ACS patients (n=30), ADP-induced platelet aGGreGAtion was assessed turbidimetrically on day 7 of therapy. Results. Among Chuvash patients, a high frequency of minor alleles was observed: ABCB1 C3435T — 60.6 %, CYP2C1917 (–806C>T) — 28.7 %, whereas the frequencies of CYP2C192 and CYP2C193 were low (9.05 % and 1.85 %, respectively). Heterozygous CT genotype of CYP2C19*17 was associated with a higher rate of recurrent MI both in the overall cohort (19.8 % vs. 8.5 % in CC carriers; p=0.049) and in the ACS subgroup (30.2 % vs. 12.9 %; p=0.037, p~CC–CT~ =0.044). Laboratory platelet aGGreGAtion assessment revealed that the highest proportion of antiplateletresistant patients was observed among heterozygotes carrying the *1/*17 genotype (rapid metabolizer phenotype), whereas no resistance cases were recorded among *17/*17 homozygotes (ultrarapid metabolizers). No statistically significant associations with recurrent MI were found for CYP2C192, CYP2C193, or ABCB1 polymorphisms. Conclusion. In Chuvash patients with CVD, including ACS, heterozygous carriage of CYP2C1917 is associated with recurrent MI, which contradicts the expected enhancement of clopidogrel antiplatelet effect (rapid metabolizer phenotype). This may indicate possible phenoconversion due to the interplay of genetic factors (ABCB1 C3435T) and drug — drug interactions (concomitant omeprazole use).
- Open Access
- 21 July 2026
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 46 (3) , 92-101
Multiplex PCR in determining the tactics of antibacterial therapy in patients with suspected culture-negative periprosthetic infection
Differential diagnosis between culture-negative periprosthetic infection (CNI) and aseptic loosening of the endoprosthesis is difficult. The frequency of CNI after knee and hip arthroplasty varies from 7 to 42 %. This is due to the difficulties of culturing low-virulence bacteria that may be involved in the infectious process. The problem of identifying pathogens with negative culture can be solved by molecular genetic diagnostic methods. Aim of the study – to evaluate the capabilities of multiplex real-time PCR in determining the tactics of prescribing antibacterial therapy to patients with instability of large joint endoprostheses with suspected periprosthetic infection with a negative result of microbiological culture. Material and methods . A single-center prospective study of 151 cases of revision surgery for instability of large joint endoprostheses was conducted. Patients were divided into two groups based on the International Consensus Meeting (ICM) criteria (2018): group 1 (n = 108) – aseptic instability, group 2 (n = 43) — PJI with negative microbiological culture. Synovial fluid, tissue biopsies, and washings from removed implants after ultrasonic treatment were examined. All samples were tested using multiplex real-time PCR using the BakScreen UPM and BakResista GLA test systems. Results . A positive PCR result was obtained in 1.9 % of cases (2 of 108) in group 1 and in 79.1 % (34 of 43) in group 2. ROC analysis showed high diagnostic efficiency of multiplex PCR: sensitivity – 79 %, specificity – 98 %, accuracy — 93 %, area under ROC curve (AUC) – 0.889. In total, positive multiplex PCR results were obtained in 36 patients’ biological material: total bacterial mass – in 41.7 % (n = 15) cases; genes of Staphylococcus species – in 44.4 % (n = 16), S. aureus – in 16.7 % (n = 6), Streptococcus spp. – in 5.6 % (n = 2), Enterococcus spp. – in 2.8 % (n = 1), Acinetobacter spp. – in 2.8 % (n = 1). Conclusions . Multiplex real-time PCR is a valuable tool for optimizing surgical tactics and prescribing targeted antibacterial therapy in patients with instability of large joint endoprostheses and negative results of microbiological testing.
- 21 July 2026
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 46 (3) , 92-101
Open AccessMultiplex PCR in determining the tactics of antibacterial therapy in patients with suspected culture-negative periprosthetic infection
Differential diagnosis between culture-negative periprosthetic infection (CNI) and aseptic loosening of the endoprosthesis is difficult. The frequency of CNI after knee and hip arthroplasty varies from 7 to 42 %. This is due to the difficulties of culturing low-virulence bacteria that may be involved in the infectious process. The problem of identifying pathogens with negative culture can be solved by molecular genetic diagnostic methods. Aim of the study – to evaluate the capabilities of multiplex real-time PCR in determining the tactics of prescribing antibacterial therapy to patients with instability of large joint endoprostheses with suspected periprosthetic infection with a negative result of microbiological culture. Material and methods . A single-center prospective study of 151 cases of revision surgery for instability of large joint endoprostheses was conducted. Patients were divided into two groups based on the International Consensus Meeting (ICM) criteria (2018): group 1 (n = 108) – aseptic instability, group 2 (n = 43) — PJI with negative microbiological culture. Synovial fluid, tissue biopsies, and washings from removed implants after ultrasonic treatment were examined. All samples were tested using multiplex real-time PCR using the BakScreen UPM and BakResista GLA test systems. Results . A positive PCR result was obtained in 1.9 % of cases (2 of 108) in group 1 and in 79.1 % (34 of 43) in group 2. ROC analysis showed high diagnostic efficiency of multiplex PCR: sensitivity – 79 %, specificity – 98 %, accuracy — 93 %, area under ROC curve (AUC) – 0.889. In total, positive multiplex PCR results were obtained in 36 patients’ biological material: total bacterial mass – in 41.7 % (n = 15) cases; genes of Staphylococcus species – in 44.4 % (n = 16), S. aureus – in 16.7 % (n = 6), Streptococcus spp. – in 5.6 % (n = 2), Enterococcus spp. – in 2.8 % (n = 1), Acinetobacter spp. – in 2.8 % (n = 1). Conclusions . Multiplex real-time PCR is a valuable tool for optimizing surgical tactics and prescribing targeted antibacterial therapy in patients with instability of large joint endoprostheses and negative results of microbiological testing.
- Open Access
- 20 July 2026
- Published by Volgograd State Medical University in Pharmacy & Pharmacology
- Vol. 14 (4) , 326-337
Development of a method for in vitro cultivation of Corti's organ explants using polyethyleneimine
The aim. To develop a method for in vitro cultivation of Corti’s organ explants using polyethyleneimine (PEI) as an adhesive substrate. The study evaluated the potential of PEI as an effective alternative to existing substrates for in vitro cultivation of inner ear samples. Materials and methods. Explants of Corti’s organ from newborn mice (P1–P2) were used. Glass culture surfaces were treated with a PEI solution followed by treatment with fetal bovine serum. To assess the suitability of the developed explant model for ototoxicity studies, treatment with gentamicin was performed. Isoliquiritigenin was used as an otoprotector. Morphological analysis of images obtained by confocal fluorescence microscopy was conducted. The survival of hair cells after staining with phalloidin labeled with Alexa Fluor 488 was evaluated. The magnitude of stereociliary angles of outer hair cells was assessed. Results. PEI- coating provided reliable fixation of Corti’s organ explants (up to 72 h) without signs of detachment from the culture surface. The samples maintained their attachment strength through two media changes and subsequent 16 washing cycles during fluorescent staining. Morphological analysis of the control group revealed no signs of toxic effects of PEI on hair cells. The organotypic model using PEI coating reproduced the classic pattern of gentamicin-induced ototoxicity with a basal-apical gradient of damage. For the first time, this model demonstrated the otoprotective effect of isoliquiritigenin (1 μM) against gentamicin-induced ototoxicity (500 μM), most pronounced in the middle turn of the cochlea for both inner and outer hair cells ( p < 0.0001 for both comparisons with the gentamicin group). Conclusion . The efficacy of PEI as an alternative substrate for cultivating inner ear samples has been demonstrated for the first time, showing optimal adhesive properties and no inherent toxicity. The developed method represents a promising approach for ototoxicity research and otoprotector screening.
- 20 July 2026
- Published by Volgograd State Medical University in Pharmacy & Pharmacology
- Vol. 14 (4) , 326-337
Open AccessDevelopment of a method for in vitro cultivation of Corti's organ explants using polyethyleneimine
The aim. To develop a method for in vitro cultivation of Corti’s organ explants using polyethyleneimine (PEI) as an adhesive substrate. The study evaluated the potential of PEI as an effective alternative to existing substrates for in vitro cultivation of inner ear samples. Materials and methods. Explants of Corti’s organ from newborn mice (P1–P2) were used. Glass culture surfaces were treated with a PEI solution followed by treatment with fetal bovine serum. To assess the suitability of the developed explant model for ototoxicity studies, treatment with gentamicin was performed. Isoliquiritigenin was used as an otoprotector. Morphological analysis of images obtained by confocal fluorescence microscopy was conducted. The survival of hair cells after staining with phalloidin labeled with Alexa Fluor 488 was evaluated. The magnitude of stereociliary angles of outer hair cells was assessed. Results. PEI- coating provided reliable fixation of Corti’s organ explants (up to 72 h) without signs of detachment from the culture surface. The samples maintained their attachment strength through two media changes and subsequent 16 washing cycles during fluorescent staining. Morphological analysis of the control group revealed no signs of toxic effects of PEI on hair cells. The organotypic model using PEI coating reproduced the classic pattern of gentamicin-induced ototoxicity with a basal-apical gradient of damage. For the first time, this model demonstrated the otoprotective effect of isoliquiritigenin (1 μM) against gentamicin-induced ototoxicity (500 μM), most pronounced in the middle turn of the cochlea for both inner and outer hair cells ( p < 0.0001 for both comparisons with the gentamicin group). Conclusion . The efficacy of PEI as an alternative substrate for cultivating inner ear samples has been demonstrated for the first time, showing optimal adhesive properties and no inherent toxicity. The developed method represents a promising approach for ototoxicity research and otoprotector screening.
- 3 October 2025
- Published by PANORAMA Publishing House
- No. 10,p. 56-64
Adverse reactions of targeted therapy for cystic fibrosis: cases of cataract development in children
Targeted therapy for cystic fibrosis with drugs modulating the transmembrane conductance regulator (CFTR) gene (ivacaftor, lumacaftor, tezacaftor, elexacaftor) has significantly improved the prognosis of the disease, but requires attention to safety issues. One of the potential side effects of ivacaftor-containing treatment regimens is cataract in children, which necessitates ophthalmological monitoring. The article presents two clinical cases of cataract development in children aged 7 and 12 years with cystic fibrosis during therapy with ivacaftor + lumacaftor and ivacaftor + tezacaftor + elexacaftor for 3 and 11 months, respectively. In both patients, lens opacity was detected (partial posterior capsular cataract in a 7-year-old girl, bilateral "secondary" cataract in a 12-year-old girl) during routine ophthalmological examination. It should be noted that visual function was not significantly impaired, and surgical treatment was not required. Therapy with suspected targeted drugs was discontinued, and the patients were transferred to alternative methods of treating cystic fibrosis. The work emphasizes the importance of pharmacovigilance methods in targeted therapy for cystic fibrosis and ophthalmological monitoring before and during treatment with ivacaftor-containing drugs to preserve patients' vision.
- 3 October 2025
- Published by PANORAMA Publishing House
- No. 10,p. 56-64
Adverse reactions of targeted therapy for cystic fibrosis: cases of cataract development in children
Targeted therapy for cystic fibrosis with drugs modulating the transmembrane conductance regulator (CFTR) gene (ivacaftor, lumacaftor, tezacaftor, elexacaftor) has significantly improved the prognosis of the disease, but requires attention to safety issues. One of the potential side effects of ivacaftor-containing treatment regimens is cataract in children, which necessitates ophthalmological monitoring. The article presents two clinical cases of cataract development in children aged 7 and 12 years with cystic fibrosis during therapy with ivacaftor + lumacaftor and ivacaftor + tezacaftor + elexacaftor for 3 and 11 months, respectively. In both patients, lens opacity was detected (partial posterior capsular cataract in a 7-year-old girl, bilateral "secondary" cataract in a 12-year-old girl) during routine ophthalmological examination. It should be noted that visual function was not significantly impaired, and surgical treatment was not required. Therapy with suspected targeted drugs was discontinued, and the patients were transferred to alternative methods of treating cystic fibrosis. The work emphasizes the importance of pharmacovigilance methods in targeted therapy for cystic fibrosis and ophthalmological monitoring before and during treatment with ivacaftor-containing drugs to preserve patients' vision.
- Open Access
- 1 September 2025
- Published by Publishing House OKI in Pharmacogenetics and Pharmacogenomics
- No. 1,p. 17-23
Polymorphisms of CYP2C9 and VKORC1 genes and their association with calcification of heart valves in Chuvash patients with chronic rheumatic heart disease
Relevance. Patients with chronic rheumatic heart disease (CRHD) often require warfarin, individual sensitivity to which is determined by polymorphisms of the CYP2C9 and VKORC1 genes. Warfarin use is associated with arterial calcification, which is explained by inhibition of the matrix protein MGP. This may be significant in CRHD, a characteristic feature of which is calcification of the heart valves. Objective. To study the polymorphisms of CYP2C9 (C430T and A1075C), VKORC1 (−1639G>A), and their association with calcification of the heart valves in Chuvash patients with CRHD receiving warfarin. Methods. The study included patients meeting the following criteria: 18–80 years old, confirmed CRHD, warfarin therapy, self-identification as an ethnicChuvash. Calcification of the valves was confirmed by echocardiography. Genotyping was performed by PCR. Results. The frequency of the A allele of the VKORC1 gene (−1639G>A) was 48.60 %, the T allele (CYP2C9*2) — 10.15%, and the C allele (CYP2C9*3) — 4.05 %. Calcification of the heart valves was detected in 75.7 % of the examined patients: the aortic (50 %) and mitral (45.9 %) valves were most often affected, while the tricuspid valve was involved less often (4.1 %). Statistical analysis demonstrated a significant association between homozygous carriage of the VKORC1 (−1639G>A) allele A and the development of aortic valve calcification (p = 0.023), while the difference between the AA and GA groups also reached statistical significance (p = 0.021). Conclusion. Identification of VKORC1 genetic variants, as well as the association of carriage of the A allele in homozygous form with valve calcification in patients with CRHD receiving warfarin therapy, can help in personalizing anticoagulant therapy, taking into account both the risks of hypocoagulation and the possible progression of heart valve calcification.
- 1 September 2025
- Published by Publishing House OKI in Pharmacogenetics and Pharmacogenomics
- No. 1,p. 17-23
Open AccessPolymorphisms of CYP2C9 and VKORC1 genes and their association with calcification of heart valves in Chuvash patients with chronic rheumatic heart disease
Relevance. Patients with chronic rheumatic heart disease (CRHD) often require warfarin, individual sensitivity to which is determined by polymorphisms of the CYP2C9 and VKORC1 genes. Warfarin use is associated with arterial calcification, which is explained by inhibition of the matrix protein MGP. This may be significant in CRHD, a characteristic feature of which is calcification of the heart valves. Objective. To study the polymorphisms of CYP2C9 (C430T and A1075C), VKORC1 (−1639G>A), and their association with calcification of the heart valves in Chuvash patients with CRHD receiving warfarin. Methods. The study included patients meeting the following criteria: 18–80 years old, confirmed CRHD, warfarin therapy, self-identification as an ethnicChuvash. Calcification of the valves was confirmed by echocardiography. Genotyping was performed by PCR. Results. The frequency of the A allele of the VKORC1 gene (−1639G>A) was 48.60 %, the T allele (CYP2C9*2) — 10.15%, and the C allele (CYP2C9*3) — 4.05 %. Calcification of the heart valves was detected in 75.7 % of the examined patients: the aortic (50 %) and mitral (45.9 %) valves were most often affected, while the tricuspid valve was involved less often (4.1 %). Statistical analysis demonstrated a significant association between homozygous carriage of the VKORC1 (−1639G>A) allele A and the development of aortic valve calcification (p = 0.023), while the difference between the AA and GA groups also reached statistical significance (p = 0.021). Conclusion. Identification of VKORC1 genetic variants, as well as the association of carriage of the A allele in homozygous form with valve calcification in patients with CRHD receiving warfarin therapy, can help in personalizing anticoagulant therapy, taking into account both the risks of hypocoagulation and the possible progression of heart valve calcification.
- 2 July 2025
- Published by PANORAMA Publishing House in Terapevt (General Physician)
- No. 7,p. 30-41
When to start, what to treat with, and how to combine? Analysis of medical students’ knowledge about arterial hypertension therapy
Arterial hypertension (AH, hypertensive disease) is one of the most significant medical and social problems of our time, requiring increased attention, including among the youth [1]. AH represents a global public health issue affecting millions of people worldwide [2]. As part of the study conducted in the 2024-2025 academic year, testing was carried out among students from universities in Yoshkar-Ola (Mari State University), Cheboksary (Chuvash State University named after I.N. Ulyanov), and Krasnoyarsk (Krasnoyarsk State Medical University named after Professor V.F. Voino-Yasenetsky) to assess their level of awareness regarding hypertension treatment. The analysis of the results has revealed that the level of knowledge about the treatment of hypertension in these groups is comparable, but overall, not sufficiently high. 42.1% of the students (from 35.7% to 44.4%) answered correctly for the first question, 16.6% (from 9.5% to 22.2%) – for the second question, 59.5% (from 58.9% to 60.0%) – for the third question, 55.5% (from 43.5% to 66.6%) – for the fourth question, and 82.5% (from 82.0% to 85.7%) – for the fifth question.
- 2 July 2025
- Published by PANORAMA Publishing House in Terapevt (General Physician)
- No. 7,p. 30-41
When to start, what to treat with, and how to combine? Analysis of medical students’ knowledge about arterial hypertension therapy
Arterial hypertension (AH, hypertensive disease) is one of the most significant medical and social problems of our time, requiring increased attention, including among the youth [1]. AH represents a global public health issue affecting millions of people worldwide [2]. As part of the study conducted in the 2024-2025 academic year, testing was carried out among students from universities in Yoshkar-Ola (Mari State University), Cheboksary (Chuvash State University named after I.N. Ulyanov), and Krasnoyarsk (Krasnoyarsk State Medical University named after Professor V.F. Voino-Yasenetsky) to assess their level of awareness regarding hypertension treatment. The analysis of the results has revealed that the level of knowledge about the treatment of hypertension in these groups is comparable, but overall, not sufficiently high. 42.1% of the students (from 35.7% to 44.4%) answered correctly for the first question, 16.6% (from 9.5% to 22.2%) – for the second question, 59.5% (from 58.9% to 60.0%) – for the third question, 55.5% (from 43.5% to 66.6%) – for the fourth question, and 82.5% (from 82.0% to 85.7%) – for the fifth question.
- Open Access
- 21 April 2025
- Published by Russian Ilizarov Scientific Centre Restorative Traumatology and Orthopaedics in Genij Ortopedii
- Vol. 31 (2) , 202-209
Etiology of infectious spondylodiscitis: is there an associaton with successful treatment?
Introduction Infectious spondylodiscitis is rising in incidence and and is often a late diagnosis and identification of the causative agent.The objective was to evaluate the treatment outcomes of patients with infectious spondylodiscitis depending on the positive/negative results of intraoperative microbiological culture.Material and methods Treatment outcomes of 52 patients with infectious spondylodiscitis were retrospectively analyzed with no culture growth in the biological samples (group I, n = 22) and with identified pathogen (group II, n = 30). The diagnosis was verified using MRI imaging, intraoperative microbiological culture test, the clinical picture and blood inflammation markers (ESR and CRP). Poor outcomes were associated with death and/or recurrent spondylodiscitis.Results Positive culture growth was detected in 57.7 % with staphylococci predominated in 57.2 % and Staphylococcus aureus detected in 42.9 %. Patients of group I were twice as likely to take antibiotics at the preadmission stage (p = 0.0049), had a 20 % longer delay in diagnosis (p = 0.7286), and had lower CRP and ESR levels than those in Group II (p > 0.05). Adverse events included one fatal case in each of the groups; recurrent infections occurred in 13.3 % of cases of group II (p = 0.3814) with three quarters of cases caused by Pseudomonas aeruginosa.Discussion Poor prognostic factors in infectious spondylodiscitis include negative microbiological results, neurological impairment and concomitant endocarditis (p ≤ 0.05). S. aureus associated spondylodiscitis is accompanied by increased mortality and morbidity. Patients with spondylodiscitis with a negative microbiological test result compared with patients with a culture-positive infection, had a better treatment outcome with minimum recurrent rate (p > 0.05).Conclusion Spondylodiscites with a negative microbiological result compared with a culture-positive infection had a better treatment outcome with a minimum of relapses (p > 0.05).
- 21 April 2025
- Published by Russian Ilizarov Scientific Centre Restorative Traumatology and Orthopaedics in Genij Ortopedii
- Vol. 31 (2) , 202-209
Open AccessEtiology of infectious spondylodiscitis: is there an associaton with successful treatment?
Introduction Infectious spondylodiscitis is rising in incidence and and is often a late diagnosis and identification of the causative agent.The objective was to evaluate the treatment outcomes of patients with infectious spondylodiscitis depending on the positive/negative results of intraoperative microbiological culture.Material and methods Treatment outcomes of 52 patients with infectious spondylodiscitis were retrospectively analyzed with no culture growth in the biological samples (group I, n = 22) and with identified pathogen (group II, n = 30). The diagnosis was verified using MRI imaging, intraoperative microbiological culture test, the clinical picture and blood inflammation markers (ESR and CRP). Poor outcomes were associated with death and/or recurrent spondylodiscitis.Results Positive culture growth was detected in 57.7 % with staphylococci predominated in 57.2 % and Staphylococcus aureus detected in 42.9 %. Patients of group I were twice as likely to take antibiotics at the preadmission stage (p = 0.0049), had a 20 % longer delay in diagnosis (p = 0.7286), and had lower CRP and ESR levels than those in Group II (p > 0.05). Adverse events included one fatal case in each of the groups; recurrent infections occurred in 13.3 % of cases of group II (p = 0.3814) with three quarters of cases caused by Pseudomonas aeruginosa.Discussion Poor prognostic factors in infectious spondylodiscitis include negative microbiological results, neurological impairment and concomitant endocarditis (p ≤ 0.05). S. aureus associated spondylodiscitis is accompanied by increased mortality and morbidity. Patients with spondylodiscitis with a negative microbiological test result compared with patients with a culture-positive infection, had a better treatment outcome with minimum recurrent rate (p > 0.05).Conclusion Spondylodiscites with a negative microbiological result compared with a culture-positive infection had a better treatment outcome with a minimum of relapses (p > 0.05).
- Open Access
- 18 December 2024
- Published by ECO-Vector LLC in Traumatology and Orthopedics of Russia
- Vol. 30 (4) , 5-13
The potential utility of synovial C-reactive protein, interleukin-6, and presepsin in diagnostics of periprosthetic joint infection
Background. Diagnostics of infectious complications in joint replacement surgery remains a significant challenge, particularly when microbiological analysis of biological material fails to reveal pathogen growth. The aim of the study was to determine threshold values for C-reactive protein, interleukin-6, and presepsin levels, and to assess their diagnostic value in detecting periprosthetic joint infection. Methods. A prospective cohort single-center blinded study was conducted involving cases of revision arthroplasty for periprosthetic joint infection (PJI) and aseptic prosthetic loosening. The study included 66 patients divided into two groups: Group I (n = 17), with confirmed PJI using the 2018 ICM criteria, and Group II (n = 49), with aseptic prosthetic loosening. Synovial fluid samples were subjected to bacteriological and cytological analysis, measuring levels of C-reactive protein (CRP), presepsin, and interleukin-6 (IL-6). ROC analysis, sensitivity, specificity, accuracy, and threshold values were determined for laboratory data. Results. The highest diagnostic accuracy in distinguishing between PJI and aseptic loosening was observed in the leukocyte count in synovial fluid (AUC 0.928; 95% CI: 0.837-0.977, p0.0001). Elevated synovial CRP levels were associated with infection, with an AUC of 0.776 (95% CI: 0.656-0.870, p = 0.0004), and IL-6 had an AUC of 0.712 (95% CI: 0.583-0.820; p = 0.0048). Presepsin levels, however, showed no significant difference between groups (AUC 0.582; 95% CI: 0.453-0.703; p = 0.3344). Threshold values were set at 5.6 mg/l for CRP, 1212.0 pg/ml for presepsin, and 988.5 pg/ml for IL-6. Sensitivity, specificity, and accuracy for PJI diagnosis were determined for CRP at 62.5%, 85.7%, and 80.0%; for IL-6 at 87.5%, 63.0%, and 69.4%; and for presepsin at 43.8%, 79.6%, and 70.8%, respectively. Conclusion. In cases where synovial leukocyte counts are at borderline levels, the additional assessment of synovial fluid cellular composition and simple, cost-effective markers such as synovial CRP and IL-6 may be recommended to confirm PJI.
- 18 December 2024
- Published by ECO-Vector LLC in Traumatology and Orthopedics of Russia
- Vol. 30 (4) , 5-13
Open AccessThe potential utility of synovial C-reactive protein, interleukin-6, and presepsin in diagnostics of periprosthetic joint infection
Background. Diagnostics of infectious complications in joint replacement surgery remains a significant challenge, particularly when microbiological analysis of biological material fails to reveal pathogen growth. The aim of the study was to determine threshold values for C-reactive protein, interleukin-6, and presepsin levels, and to assess their diagnostic value in detecting periprosthetic joint infection. Methods. A prospective cohort single-center blinded study was conducted involving cases of revision arthroplasty for periprosthetic joint infection (PJI) and aseptic prosthetic loosening. The study included 66 patients divided into two groups: Group I (n = 17), with confirmed PJI using the 2018 ICM criteria, and Group II (n = 49), with aseptic prosthetic loosening. Synovial fluid samples were subjected to bacteriological and cytological analysis, measuring levels of C-reactive protein (CRP), presepsin, and interleukin-6 (IL-6). ROC analysis, sensitivity, specificity, accuracy, and threshold values were determined for laboratory data. Results. The highest diagnostic accuracy in distinguishing between PJI and aseptic loosening was observed in the leukocyte count in synovial fluid (AUC 0.928; 95% CI: 0.837-0.977, p0.0001). Elevated synovial CRP levels were associated with infection, with an AUC of 0.776 (95% CI: 0.656-0.870, p = 0.0004), and IL-6 had an AUC of 0.712 (95% CI: 0.583-0.820; p = 0.0048). Presepsin levels, however, showed no significant difference between groups (AUC 0.582; 95% CI: 0.453-0.703; p = 0.3344). Threshold values were set at 5.6 mg/l for CRP, 1212.0 pg/ml for presepsin, and 988.5 pg/ml for IL-6. Sensitivity, specificity, and accuracy for PJI diagnosis were determined for CRP at 62.5%, 85.7%, and 80.0%; for IL-6 at 87.5%, 63.0%, and 69.4%; and for presepsin at 43.8%, 79.6%, and 70.8%, respectively. Conclusion. In cases where synovial leukocyte counts are at borderline levels, the additional assessment of synovial fluid cellular composition and simple, cost-effective markers such as synovial CRP and IL-6 may be recommended to confirm PJI.
- 30 September 2024
- Published by I.N. Ulianov Chuvash State University in Acta medica Eurasica
- No. 3
Analysis of Recurrent Haemorrhage Against the Background of Taking Warfarin in a Female Patient of the Chuvash Population (a clinical case)
In order to prevent thromboembolic complications in atrial fibrillation in patients with prosthetic heart valves, Warfarin still remains a standard drug in real-life clinical practice. However, against the background of Warfarin therapy, haemorrhage is common; in some cases it can be fatal. The reason for this situation lies in a narrow therapeutic range and wide individual dosage variations of this drug. Among the factors determining the effectiveness and safety of Warfarin, modifiable (for example, drug interactions, bad habits) and non-modifiable (age, gender, genetic characteristics) ones are considered important. The authors of the paper analyzed possible causes of haemorrhage and difficulties with Warfarin dose finding and achievement of targets for international normalized ratio in a female patient who was passing treatment at the Budgetary Institution "Republican Cardiological Dispensary" under the Health Ministry of the Chuvash Republic. Patient K. (a female Chuvash, 68 years old), who received Warfarin for valvular atrial fibrillation, was repeatedly hospitalized (April 2023, August 2023) with signs of haemorrhage after self-medicating with non-steroidal anti-inflammatory drugs and Cephalosporin antibiotics. Among other factors predisposing to changes in sensitivity to Warfarin, the following were identified: old age, female gender, increased body mass index. However, the carrier state of polymorphism in CYP2C9 and VKORC1 genes that increase sensitivity to Warfarin were not diagnosed. Additional difficulties in achieving the targets of international normalized ratio could be associated with the replacement of the drug taken to Warfarin from another manufacturer. The analysis of recurrent cases of hypocoagulation and difficulties in achieving the target values of the international normalized ratio against the background of taking Warfarin did not reveal pharmacogenetic risk factors, but was most likely associated with low compliance, undesirable drug interactions and differences in the therapeutic equivalence of Warfarin drugs used. With the help of a regional medical information system, the patient's condition was updated, the data obtained indicate a possible risk of recurrent haemorrhage, which is probably due to a change in the manufacturer of Warfarin.
- 30 September 2024
- Published by I.N. Ulianov Chuvash State University in Acta medica Eurasica
- No. 3
Analysis of Recurrent Haemorrhage Against the Background of Taking Warfarin in a Female Patient of the Chuvash Population (a clinical case)
In order to prevent thromboembolic complications in atrial fibrillation in patients with prosthetic heart valves, Warfarin still remains a standard drug in real-life clinical practice. However, against the background of Warfarin therapy, haemorrhage is common; in some cases it can be fatal. The reason for this situation lies in a narrow therapeutic range and wide individual dosage variations of this drug. Among the factors determining the effectiveness and safety of Warfarin, modifiable (for example, drug interactions, bad habits) and non-modifiable (age, gender, genetic characteristics) ones are considered important. The authors of the paper analyzed possible causes of haemorrhage and difficulties with Warfarin dose finding and achievement of targets for international normalized ratio in a female patient who was passing treatment at the Budgetary Institution "Republican Cardiological Dispensary" under the Health Ministry of the Chuvash Republic. Patient K. (a female Chuvash, 68 years old), who received Warfarin for valvular atrial fibrillation, was repeatedly hospitalized (April 2023, August 2023) with signs of haemorrhage after self-medicating with non-steroidal anti-inflammatory drugs and Cephalosporin antibiotics. Among other factors predisposing to changes in sensitivity to Warfarin, the following were identified: old age, female gender, increased body mass index. However, the carrier state of polymorphism in CYP2C9 and VKORC1 genes that increase sensitivity to Warfarin were not diagnosed. Additional difficulties in achieving the targets of international normalized ratio could be associated with the replacement of the drug taken to Warfarin from another manufacturer. The analysis of recurrent cases of hypocoagulation and difficulties in achieving the target values of the international normalized ratio against the background of taking Warfarin did not reveal pharmacogenetic risk factors, but was most likely associated with low compliance, undesirable drug interactions and differences in the therapeutic equivalence of Warfarin drugs used. With the help of a regional medical information system, the patient's condition was updated, the data obtained indicate a possible risk of recurrent haemorrhage, which is probably due to a change in the manufacturer of Warfarin.